Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-12-21

Clinical Trial Update: The Role of COX-2 Inhibition in Salt Sensitivity of Blood Pressure [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the role of COX-2 inhibition in salt sensitivity of blood pressure in hypertension; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Delaware | Conditions: Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2011-12-21